王培钰 助理教授
王培钰博士，中共党员，厦门大学公共卫生学院助理教授，主要从事大气压低温等离子体设备研发及临床转化研究。入选“博士后国际交流计划-引进项目”，获第三届博士后创新创业大赛国赛金奖，福建省优秀博士后等荣誉。已在Sci. Adv., Adv. Sci., Chin. Chem. Lett.等国际高水平期刊发表SCI论文29篇，其中第一/通讯作者15篇，8篇入选高被引论文，总引用2000余次。主持国家自然科学基金青年项目1项、主持中国博士后科学基金项目2项，翔安创新实验培育项目1项，参与国家级项目3项，国际重点研发1项。研究成果被新华社等媒体报道，总浏览量逾10万。
教育经历与工作经历：
(1) 2026-07 至今, 厦门大学公共卫生学院, 助理教授
(2) 2021-02 至 2026-07, 厦门大学公共卫生学院刘刚教授课题组, 博士后
(3) 2017-07 至 2021-02, 澳大利亚昆士兰科技大学(QUT), 博士, QUTPRA全额奖学金
(4) 2014-09 至 2017-06, 厦门大学, 化学生物学, 硕士
(5) 2010-09 至 2014-06, 厦门大学, 药学, 学士
代表性论文：
[1] Li S*, Wang P*, Wu Z. …, Gang Liu (2026) Cold atmospheric plasma–engineered nanovaccine with spatiotemporal sequential immunization reprograms antitumor immunity. Science Advances, 12 (13), eaeb5894.
[2] Wang P, Zhou R, Zhou R, et al. Epidermal Growth Factor potentiates EGFR (Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium[J]. Redox Biology, 2024: 102976.
[3] Wang P, Zhou R, Zhou R, et al. Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry[J]. Theranostics, 2022, 12(6): 2811.
[4] Zheng Y, Zhuang Z, …, Liu G, Zeng Y*, Wang P*. Next‐Generation Oral Ulcer Management: Integrating Cold Atmospheric Plasma (CAP) with Nanogel‐Based Pharmaceuticals for Inflammation Regulation[J]. Advanced Healthcare Materials, 2403223.
[5] Zhuang, Z., Cheng, M., Zhang, D., Shi, J., Wang, K., Jiang, X., ... & Wang, P. (2026). DualVision: A comparative study of ultraviolet–near infrared imaging and deep neural networks for Epimedii Folium identification. Chinese Chemical Letters, 112420.
[6] Li, C., Cheng, H., Zhuang, Z., Cao, F., ..., Wang P*, Liu, G*. (2025). FlexiPlasma Microcatheter–Embolic Material (FPM‐EM) Platform: A Non‐Inflammatory Pyroptosis Strategy for Precision Hepatocellular Carcinoma Therapy. Small Methods, 2500231.
[7] Zhuang, Z., Zhang, L., Thompson, E. W., Zeng, Y., ..., Wang P*, Liu, G*. (2026). Cold atmospheric plasma redefining antiviral innovation for post-pandemic challenges. Chinese Chemical Letters, 112444.
[8] Wang S*, Wang P*, Thompson R, et al. Plasma‐activated medium triggers immunomodulation and autophagic activity for periodontal regeneration[J]. Bioengineering & Translational Medicine, 2023: e10528.
[9] Zhang L, Yang B,…, Wang P*, Liu G*, Wen X*, You Y*. Carrier-free Nano-Tetrandrine (PURE-T) for Psoriasis Treatment: Significant Therapeutic Efficacy and Its Regulatory Mechanism on Stratum Corneum Inflammation[J]. ACS Applied Materials & Interfaces, 2025.
[10] Dai X, Pilar B, Wang P, Sgro A, Thompson EW, Ostrikov KK. Innovative precision gene-editing tools in personalized cancer medicine. Advanced Science. 2020 7(12): 1902552.
会议论文及汇报：
[1] 王培钰，(2025) 解析大气压冷等离子体潜在的抗病原分子机制，第二届全国等离子体生物医学学术会议，邀请报告，深圳，中国。
[2] Lu, X., Wang, K., Wang, P., Zhang, Q., Zhao, Y., Liu, G., & Yu, X. (2025, June). Gate-ViT: Gated Vision Transformer for Fine-Grained Visual Classification. In Pacific-Asia Conference on Knowledge Discovery and Data Mining (pp. 468-479). Singapore: Springer Nature Singapore.
[3] Wang P. (2024) Dissecting the Molecular Mechanisms of Potential Cold Atmospheric Plasma-Based Pathogen Defense, 17th International Conference on Plasma Science and Applications (ICPSA 2024), Invited speaker, Kuala Lumpur, Malaysia
[4] Lu X, Yu X, Wang K, Wang Y, Wang P, Liu Gang. SupCon-ViT: Supervised contrastive learning for ultra-fine-grained visual categorization[C]//2023 International Conference on Digital Image Computing: Techniques and Applications (DICTA). IEEE, 2023: 281-288.
[5] Wang P. (2022) Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry The 20th National Conference on Plasma Science and Technology, 24 April 2022
[6] Wang P. (2022) Cold atmospheric plasma therapy selectively targets triple negative breast cancer cells. AACR annual meeting, #4323, 10 April 2022.